Coya Therapeutics, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -312.7% | – | – | – | – | – | – | – | – | – | |
| – | 0.0% | +0.0% | +0.0% | +0.0% | 0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -59.0% | +199,800.0% | – | |
| – | -9.4% | +83.1% | +52.0% | +17.0% | +2.0% | +36.6% | -4.1% | +3.4% | +3.1% | +98.9% | +142,792.7% | – | |
| – | -521.4% | – | -134.8% | – | – | – | -121.3% | – | – | -166.6% | – | – | |
| – | – | – | -100.0% | -33.3% | +50.0% | +1,666,666.7% | -100.0% | -25.0% | +0.0% | -100.0% | – | – | |
| – | – | -87.1% | – | – | – | – | – | – | +25.7% | +36.4% | +99,987.1% | – | |
| – | – | -94.9% | +314.7% | -101.1% | – | -99.8% | -100.0% | – | +106,231.5% | -46.0% | +197,809.6% | – | |
| – | – | -84.5% | -82.6% | -1,042.1% | – | -138.6% | – | – | – | -79.1% | +184,450.0% | – | |
| – | – | – | -312.7% | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.